{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T02:56:01Z","timestamp":1648522561851},"reference-count":23,"publisher":"Oxford University Press (OUP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mod Rheumatol"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1007\/s10165-011-0511-y","type":"journal-article","created":{"date-parts":[[2011,9,6]],"date-time":"2011-09-06T17:22:57Z","timestamp":1315329777000},"page":"195-201","source":"Crossref","is-referenced-by-count":0,"title":["Delayed treatment with tumor necrosis factor inhibitors in incomplete responders to synthetic disease-modifying anti-rheumatic drugs shows an excellent effect in patients with very early rheumatoid arthritis with poor prognosis factors"],"prefix":"10.1093","volume":"22","author":[{"given":"Junko","family":"Kita","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mami","family":"Tamai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiko","family":"Arima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshikazu","family":"Nakashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahisa","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin-ya","family":"Kawashiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akitomo","family":"Okada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiro","family":"Koga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Yamasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoki","family":"Origuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiyuki","family":"Aramaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Munetoshi","family":"Nakashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keita","family":"Fujikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiaki","family":"Tsukada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Ida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyoshi","family":"Aoyagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masataka","family":"Uetani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsumi","family":"Eguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Kawakami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2011,9,6]]},"reference":[{"key":"511_CR1","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1002\/1529-0131(200110)44:10<2242::AID-ART386>3.0.CO;2-F","volume":"44","author":"M Boers","year":"2001","unstructured":"Boers M, Kostense PJ, Verhoeven AC, van der Linden S, COBRA Trial Group (Combinatietherapie Bij Reumatoide Artritis). Inflammation and damage in an individual joint predict further damage in that joint in patients with early rheumatoid arthritis. Arthritis Rheum. 2001;44:2242\u20136.","journal-title":"Arthritis Rheum"},{"key":"511_CR2","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/00000441-200204000-00002","volume":"323","author":"JK Jenkins","year":"2002","unstructured":"Jenkins JK, Hardy KJ, McMurray RW. The pathogenesis of rheumatoid arthritis: a guide to therapy. Am J Med Sci. 2002;323:171\u201380.","journal-title":"Am J Med Sci"},{"key":"511_CR3","unstructured":"Haraoui B, Pope J. Treatment of early rheumatoid arthritis: concepts in management. Semin Arthritis Rheum. 2011;40:371\u201388."},{"key":"511_CR4","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1136\/ard.2005.044354","volume":"66","author":"B Combe","year":"2007","unstructured":"Combe B, Landewe R, Lukas C, Bolosiu HD, Breedveld F, Dougados M, et al. EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis. 2007;66:34\u201345.","journal-title":"Ann Rheum Dis"},{"key":"511_CR5","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","volume":"62","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO 3rd, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2010;62:2569\u201381.","journal-title":"Arthritis Rheum"},{"key":"511_CR6","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1136\/ard.2010.138461","volume":"69","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO 3rd, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Ann Rheum Dis. 2010;69:1580\u20138.","journal-title":"Ann Rheum Dis"},{"key":"511_CR7","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1136\/ard.2009.123919","volume":"69","author":"JS Smolen","year":"2010","unstructured":"Smolen JS, Aletaha D, Bijlsma JW, Breedveld FC, Boumpas D, Burmester G, et al. Treating rheumatoid arthritis to target: recommendations of an international task force. Ann Rheum Dis. 2010;69:631\u20137.","journal-title":"Ann Rheum Dis"},{"key":"511_CR8","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1002\/art.21405","volume":"52","author":"YP Goekoop-Ruiterman","year":"2005","unstructured":"Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Allaart CF, van Zeben D, Kerstens PJ, Hazes JM, et al. Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial. Arthritis Rheum. 2005;52:3381\u201390.","journal-title":"Arthritis Rheum"},{"key":"511_CR9","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1002\/art.22718","volume":"56","author":"AE Bijl van der","year":"2007","unstructured":"van der Bijl AE, Goekoop-Ruiterman YP, de Vries-Bouwstra JK, ten Wolde S, Han KH, van Krugten MV, et al. Infliximab and methotrexate as induction therapy in patients with early rheumatoid arthritis. Arthritis Rheum. 2007;56:2129\u201334.","journal-title":"Arthritis Rheum"},{"key":"511_CR10","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1136\/ard.2008.093294","volume":"68","author":"SM Kooij van der","year":"2009","unstructured":"van der Kooij SM, le Cessie S, Goekoop-Ruiterman YP, de Vries-Bouwstra JK, van Zeben D, Kerstens PJ, et al. Clinical and radiological efficacy of initial vs delayed treatment with infliximab plus methotrexate in patients with early rheumatoid arthritis. Ann Rheum Dis. 2009;68:1153\u20138.","journal-title":"Ann Rheum Dis"},{"key":"511_CR11","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1136\/ard.2010.136556","volume":"70","author":"NB Klarenbeek","year":"2011","unstructured":"Klarenbeek NB, van der Kooij SM, G\u00fcler-Y\u00fcksel M, van Groenendael JH, Han KH, Kerstens PJ, et al. Discontinuing treatment in patients with rheumatoid arthritis in sustained clinical remission: exploratory analyses from the BeSt study. Ann Rheum Dis. 2011;70:315\u20139.","journal-title":"Ann Rheum Dis"},{"key":"511_CR12","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.berh.2007.02.004","volume":"21","author":"D Aletaha","year":"2007","unstructured":"Aletaha D, Smolen JS. The Simplified Disease Activity Index (SDAI) and Clinical Disease Activity Index (CDAI) to monitor patients in standard clinical care. Best Pract Res Clin Rheumatol. 2007;21:663\u201375.","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"511_CR13","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1136\/ard.2005.04138","volume":"65","author":"M Tamai","year":"2006","unstructured":"Tamai M, Kawakami A, Uetani M, Takao S, Tanaka F, Nakamura H, et al. The presence of anti-cyclic citrullinated peptide antibody is associated with magnetic resonance imaging detection of bone marrow oedema in early stage rheumatoid arthritis. Ann Rheum Dis. 2006;65:133\u20134.","journal-title":"Ann Rheum Dis"},{"key":"511_CR14","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1136\/ard.2005.043075","volume":"65","author":"M Tamai","year":"2006","unstructured":"Tamai M, Kawakami A, Uetani M, Takao S, Rashid H, Tanaka F, et al. Early prediction of rheumatoid arthritis by serological variables and magnetic resonance imaging of the wrists and finger joints: results from prospective clinical examination. Ann Rheum Dis. 2006;65:134\u20135.","journal-title":"Ann Rheum Dis"},{"key":"511_CR15","first-page":"2154","volume":"34","author":"M Tamai","year":"2007","unstructured":"Tamai M, Kawakami A, Uetani M, Takao S, Tanaka F, Fujikawa K, et al. Bone edema determined by magnetic resonance imaging reflects severe disease status in patients with early-stage rheumatoid arthritis. J Rheumatol. 2007;34:2154\u20137.","journal-title":"J Rheumatol"},{"key":"511_CR16","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1002\/art.24711","volume":"61","author":"M Tamai","year":"2009","unstructured":"Tamai M, Kawakami A, Uetani M, Takao S, Arima K, Iwamoto N, et al. A prediction rule for disease outcome in patients with undifferentiated arthritis using magnetic resonance imaging of the wrists and finger joints and serologic autoantibodies. Arthritis Rheum. 2009;61:772\u20138.","journal-title":"Arthritis Rheum"},{"key":"511_CR17","first-page":"436","volume":"63","author":"M Tamai","year":"2010","unstructured":"Tamai M, Kawakami A, Iwamoto N, Kawashiri SY, Fujikawa K, Aramaki T, et al. Comparative study of the detection of joint injury in early-stage rheumatoid arthritis by MRI of wrist and finger joints and physical examination. Arthritis Care Res. 2010;63:436\u20139.","journal-title":"Arthritis Care Res"},{"key":"511_CR18","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/rheumatology\/kem250","volume":"47","author":"RJ Hodgson","year":"2008","unstructured":"Hodgson RJ, O\u2019Connor P, Moots R. MRI of rheumatoid arthritis\u2014image quantitation for the assessment of disease activity, progression and response to therapy. Rheumatology. 2008;47:13\u201321.","journal-title":"Rheumatology"},{"key":"511_CR19","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.berh.2008.09.014","volume":"22","author":"M \u00d8stergaard","year":"2008","unstructured":"\u00d8stergaard M, Pedersen SJ, D\u00f8hn UM. Imaging in rheumatoid arthritis\u2014status and recent advances for magnetic resonance imaging, ultrasonography, computed tomography and conventional radiography. Best Pract Res Clin Rheumatol. 2008;22:1019\u201344.","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"511_CR20","unstructured":"Sakai R, Komano Y, Tanaka M, Nanki T, Koike R, Nakajima A, et al. The REAL database reveals no significant risk of serious infection during treatment with a methotrexate dose of more than 8\u00a0mg\/week in patients with rheumatoid arthritis. Mod Rheumatol. 2011;21:444\u20138."},{"key":"511_CR21","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1093\/rheumatology\/keh199","volume":"43","author":"VP Nell","year":"2004","unstructured":"Nell VP, Machold KP, Eberl G, Stamm TA, Uffmann M, Smolen JS. Benefit of very early referral and very early therapy with disease-modifying anti-rheumatic drugs in patients with early rheumatoid arthritis. Rheumatology. 2004;43:906\u201314.","journal-title":"Rheumatology"},{"key":"511_CR22","first-page":"365","volume":"28","author":"H Nagasawa","year":"2010","unstructured":"Nagasawa H, Kameda H, Sekiguchi N, Amano K, Takeuchi T. Normalization of physical function by infliximab in patients with RA: factors associated with normal physical function. Clin Exp Rheumatol. 2010;28:365\u201372.","journal-title":"Clin Exp Rheumatol"},{"key":"511_CR23","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1136\/ard.2009.126532","volume":"69","author":"JS Smolen","year":"2010","unstructured":"Smolen JS, Landew\u00e9 R, Breedveld FC, Dougados M, Emery P, Gaujoux-Viala C, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Ann Rheum Dis. 2010;69:964\u201375.","journal-title":"Ann Rheum Dis"}],"container-title":["Modern Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s10165-011-0511-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T16:27:46Z","timestamp":1646843266000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10165-011-0511-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9,6]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["511"],"URL":"https:\/\/doi.org\/10.1007\/s10165-011-0511-y","relation":{},"ISSN":["1439-7595","1439-7609"],"issn-type":[{"value":"1439-7595","type":"print"},{"value":"1439-7609","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9,6]]}}}